Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
The course of inflammatory bowel disease after liver transplantation has been reported as variable with usually no change or improvement, but there may be an increased risk of early colorectal neoplasms. In many centres steroids are often withdrawn early after transplantation and this may affect inflammatory bowel disease activity.
|Title:||Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.|
|Keywords:||Adolescent, Adult, Cholangitis, Sclerosing, Colitis, Ulcerative, Cyclosporine, Female, Graft Survival, Humans, Immunosuppression, Immunosuppressive Agents, Liver Transplantation, Male, Middle Aged, Precancerous Conditions, Risk Factors, Tacrolimus|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)
Archive Staff Only